Bristol-Myers Squibb reports $2.3B net loss Q4 2017, compared to net earnings of $894M in 2016
The fourth quarter and full year of 2017 Bristol-Myers Squibb were highlighted by sales for Opdivo and Eliquis, in addition to regulatory and…
Pharmaceuticals, Biotechnology and Life Sciences
The fourth quarter and full year of 2017 Bristol-Myers Squibb were highlighted by sales for Opdivo and Eliquis, in addition to regulatory and…
Premaitha Health has announced that the IONA test has been approved by Brazil’s regulatory authority, Agência Nacional de Vigilância Sanitária…
Alexion Pharmaceuticals has adde Judith A. Reinsdorf to its Board of Directors.
Emblem Corp, licensed producer and distributor of medical cannabis and cannabis derivatives in Canada, said Monday that that its director…
Allergan said Monday it has named Matt Walsh, an experienced Chief Financial Officer, to lead the financial sector of the…
GW Pharmaceuticals, a biopharmaceutical company focused on making and selling therapeutics from its cannabinoid product platform, said Monday that the…
Shire said on Monday that it will have 12 presentations at the 14th annual WORLDSymposium 2018 in San Diego, in…
Nymox Pharmaceutical will submit a New Drug Application (NDA) for Fexapotide Triflutate for the treatment of BPH in the US,…
As a media partner for this year’s Pharmapack event in Paris, Pharmaceutical Daily has interviewed Elena Piazza, Business Development and…
At Pharmapack in Paris, Spang & Brands is going to spotlight two innovative pharmaceutical devices: A single-use nasal dosing device…